Connect with us

Health

NSIA Outlines Aggressive Healthcare Expansion Plan

Published

on

NSIA Healthcare Development Investment Company

**As Authority’s Infrastructure Intervention Excites Reps Committee Chairman

The Nigeria Sovereign Investment Authority on Monday received members of the House of Representatives who were in Lagos to inspect projects undertaken by the Authority and their impact on the economy.

Key areas of focus for the Lagos visits were Healthcare, Infrastructure and Agriculture.

The Ad-hoc Committee was constituted by the House of Representatives to investigate the activities of the Nigeria Sovereign Investment Authority (NSIA) since the inception of the Authority.

The committee during the visit hailed the management of the NSIA on their intervention in the healthcare sector.

The members of the House commenced their visit at the NSIA – LUTH Cancer Centre where the Chairman of the Committee, Hon. Ademorin Kuye, said the lawmakers were impressed with the quality of service being rendered to Nigerians at the cancer centre.

Since its inception, healthcare has been a keen area of focus for the Authority, deriving from this, the NSIA Healthcare Development Investment Company was established to catalyze private sector investments to address the infrastructure gaps in the healthcare sector, improve manpower, and forge strategic collaborations to advance healthcare indicators in the country.

Established in 2019, the NLCC – an outpatient cancer centre equipped with modern medical infrastructure has attended to over 10,000 unique persons living with cancer and has also deepened the capacity of medical and non-medical professionals within the oncology space.

Over the years, NLCC has reduced capital flight from medical tourism occasioned by cancer, created direct and indirect jobs and improved access to quality cancer care, thereby expanding possibilities for people living with cancer.

In addition to NLCC, the NSIA has also invested in two modern medical diagnostic centres collocated within the Aminu Kano Teaching Hospital and Federal Medical Center, Umuahia respectively.

NSIA is now in the process of scaling these interventions, with 3 additional Oncology centres, 23 additional diagnostic centres and 7 catheterization laboratories across the six geopolitical zones of Nigeria. NSIA’s wholly-owned medical services portfolio company, Medserve, has been set up to implement these projects.

The Committee Chairman said the facilities align with the vision and commitment of the government to ensure affordable and efficient cancer care for Nigerians.

He explained, “We are investigating how much has been put into the development of this place. We have seen a lot of modern medical equipment that has been brought to this place.

“We are also seeing the quality of service being rendered to Nigerians and we are impressed and we will go back to report to the entire parliament and tell them that we need more of this in other places.”

He revealed that while talking to patients that they met during the oversight, they, “admitted that the charges here are the lowest compared to what happens in other areas like Ghana and other African countries. They are still pleading that the government should subsidize it more.

“We noted suggestions, which will be taken to the house to deliberate on. Nigeria already has centres for treating infectious diseases with qualified experts on it.

“But we will continue to develop more, we do not have enough cancer centres and there is a need for more investment in our health sector.

“And the government has assured us that they will continue to do that. And we at the parliament, will continue to appropriate sufficient funds.”

Also speaking during the visit by the lawmakers, the Managing Director of NSIA Healthcare Development Investment Company, Dr Tolulope Adewole, revealed ongoing expansion by the Authority, as part of efforts to contribute towards addressing the country’s healthcare challenges.

“We have started the expansion plan already, We had MoUs signed by different states, signed with different tertiary hospitals, and some of the equipment needed is ready to be disbursed.

“We hope to go live in the next 24 months We have a project in which we are building four diagnostic hospitals, in each geo-political zone and that will be done in two phases.

“We are upscaling from one oncology centre to four: one in the north, east, and finally Abuja. The cost is variable, so we can’t say what it will all cost us, ” he added.

The Committee also visited the Golden Fertilizer Company Limited blending plant resuscitated under the Presidential Fertilizer Initiative managed by the NSIA.

The PFI was designed in 2016 to consistently deliver commercially significant quantities of affordable, high-quality fertilizer to Nigerian farmers.

PFI was also designed to revive the local blending industry and adopt an import substitution approach by ensuring that over 60 per cent of urea and limestone required for the production of fertilizers are sourced locally at the revived blending plants.

The PFI has so far revived and established over 70 blending plants including Golden, and Apapa, – across the 6 geo-political zones in Nigeria.

The Initiative also facilitated local production and supply of NPK at affordable prices to farmers, which has correspondingly improved food security and slowed down food inflation in Nigeria.

Additionally, the PFI has reduced capital flight through import substitution, delivered over 60 million, 50kg bags of fertilizer and created more than 100,000 direct/indirect jobs within Nigeria.

By expanding production capacity for the blenders under the Presidential Fertilizer Initiative, the prices of NPK have dropped from about N11,000 per 50kg bag in 2016 to 5,000 per 50kg bag in 2020.

During the inspection of the fertilizer blending plant, the Committee expressed satisfaction with the impact that the initiative is creating in terms of job creation, food availability, forex conservation, and increase in yield for farmers.

They, however, pledged to assist in ensuring that middlemen don’t take advantage of the good intentions of the government under the initiative to create scarcity of the product and exhort Nigerians.

The Committee rounded off their assignment with a visit to the Lagos Ibadan Expressway, a 127.6 km long, busy interstate road, that cuts through Lagos, Ogun and Oyo states.

The Chairman expressed satisfaction with the progress of the project.

The Lagos-Ibadan Expressway is one of the oldest and busiest routes in Africa with the potential to unlock significant economic activities and support the seamless movement of people, goods and services around Lagos, Oyo and Ogun States.

The Lagos Ibadan Expressway is one of the projects under the Presidential Infrastructure Development Fund.

The PIDF was established by the Presidency in 2018 to accelerate the execution of certain critical infrastructure projects pivotal for the country’s development.

The NSIA was mandated by the Presidency to act as project and fund managers for the projects under PIDF.

Other infrastructure projects under the PIDF also managed by the NSIA include Abuja – Kano Road and Second Niger Bridge.

The financing of these projects has the potential to yield between 274,000 to 616,000 direct and indirect jobs.

During the visit, the NSIA Executive Director of Investments, Mr Kola Owodunni, told the lawmakers that the Authority NSIA remains focused on enabling overall socio-economic growth through diversification for Nigerians across key sectors including innovation and technology, agriculture, power, gas industrialization and financial market infrastructure.

Click to comment

Leave a Reply

Health

FG Begins Vaccination Against Mpox in FCT, Six States

Published

on

Monkeypox mpox

By Adedapo Adesanya

The Federal Ministry of Health and Social Welfare through the National Primary Health Care Development Agency (NPHCDA) has commenced the vaccination against Monkeypox, now known as Mpox.

Business Post reports that Bayelsa, Rivers, Cross River, Akwa Ibom, Enugu, Benue, and the Federal Capital Territory, were selected as pilot states for the vaccination.

An average of 631 persons are expected to be vaccinated across the seven states with two doses of the Mpox vaccine. A buffer for 50 persons will be kept at the national in case of an upsurge in other states.

NPHCDA in a statement posted on its verified X account confirmed the exercise, stressing that the vaccination will help to protect communities and safeguarding health of the people.

In a related development, according to the latest update by the Nigeria Centre for Disease Control (NCDC), there are 1,442 suspected cases of Mpox from 36 states and the Federal Capital Territory, while the number of confirmed cases of the infection was 118 from 28 states and the FCT.

“To prevent the spread of Mpox, we strongly advise the public to avoid contact with animals that may carry the virus, including sick or dead animals in affected areas, avoid handling materials that have been in contact with infected animals, limit unnecessary physical contact with individuals who are infected, practice frequent handwashing with soap and water, and ensure that animal food products are thoroughly cooked before eating.

“It’s also important to use protective clothing and gloves when handling sick animals or their tissues. Similarly, health workers are advised to follow standard safety protocols including droplet precautions when treating patients, use protective equipment including masks, gloves, and gowns, during patient care, and be vigilant for symptoms of Mpox, especially fever and rash, among other measures.”

Continue Reading

Health

AXA Mansard Health Partners LUTH in Blood Donation Drive

Published

on

Axa Mansard

By Aduragbemi Omiyale

Over 250 pints of blood have been donated by AXA Mansard Health to the Lagos University Teaching Hospital (LUTH), Idi Araba.

The blood was donated by more than 100 employees of the leading health insurance company in Nigeria through its volunteering programme tagged AXA Hearts in Action.

The initiative is part of the company’s blood donation drive aimed at contributing to positive societal and environmental impacts through employee volunteering, and expertise related financial support and in-kind donations.

According to the Chief Client Officer of AXA Mansard, Ms Rashidat Adebisi, “Through the AHIA, our employees do not just give time to great causes; we work together for a better future.”

“We share our time, knowledge and expertise as a people with a shared purpose of acting for human progress by protecting what matters through initiatives like this,” she added.

Ms Adebisi said the blood drive is a shining example of the philosophy in action, where collective contributions serve as a reminder that true impact often involves giving more than just money. It’s about putting one’s heart in action – an idea embedded in AXA’s corporate culture.

On his part, the chief executive of AXA Mansard Health Limited, Mr Tope Adeniyi, said with hospitals frequently experiencing blood shortages, events like these serve as a lifeline for patients in need.

“We are proud to contribute to the local healthcare sector and provide much-needed support to hospitals such as LUTH, ensuring that they have resources essential to saving lives,” he added.

Also commenting, the Head of Corporate Services and Public Relations at LUTH, Omolola Olubukunola Fakeye, thanked the firm for the “generous support,” which has made a “meaningful difference to our blood bank and ultimately to the lives of patients.”

“Blood donations are invaluable in many critical treatments, and initiatives like AXA Mansard’s blood drive bring immense relief to healthcare system.

“We are sincerely grateful for this partnership and the dedication of AXA Mansard’s employees,” Fakeye stated.

AXA Hearts in Action operates globally, she urging AXA employees everywhere to engage with and give back to their communities.

Through diverse projects – from health initiatives like this blood drive and medical outreaches to environmental efforts like the AXA Week for Good “Trash-to-Treasure” waste management project – AXA staff have opportunities to make a lasting difference on issues that matter.

For AXA Mansard, every act of social service brings them closer to the communities they serve, helping build a world where giving back is not only about charity but about lasting, positive change.

Continue Reading

Health

US Buys 4.8 million Swipha Malaria Doses for Nigeria, Others

Published

on

Swipha

By Adedapo Adesanya

The US Agency for International Development (USAID) has committed $2.3 million to procure 4.8 million doses of life-saving malaria tablets from Swiss Pharma (Swipha) in a landmark partnership that will expand access to essential medicines in Nigeria and West Africa.

This procurement, to be facilitated through the U.S. Government’s President’s Malaria Initiative (PMI), underscores the United States’ dedication to advancing Nigeria’s healthcare infrastructure and ensuring life-saving treatments reach vulnerable communities.

For years, Nigeria has faced significant challenges in procuring affordable, high-quality medicines due to the high cost of production and the inability of many local pharmaceutical companies to meet international quality standards.

According to the World Health Organization (WHO), fewer than 10 per cent of medicines manufactured in sub-Saharan Africa meet global standards, limiting local companies’ ability to supply essential drugs and meet healthcare needs.

These barriers have particularly affected access to medicines for malaria and child health, as local production has often fallen short of both quality and quantity requirements.

In response, USAID partnered with Swipha in their efforts to attain World Health Organization (WHO) prequalification for sulfadoxine/pyrimethamine (SP) tablets, a vital medicine for malaria prevention during pregnancy.

Swipha is now the first pharmaceutical company in Nigeria and in West Africa to achieve this WHO certification, marking a critical step forward for the region’s pharmaceutical capacity.

“USAID’s support was pivotal in helping us reach this milestone,” said Swipha Managing Director, Mr Frederic Lieutaud.

“The WHO prequalification not only validates our commitment to producing high-quality medicines but also enhances our capacity to scale production and serve both local and international markets with trusted, essential medicines.”

With the WHO prequalification, Swipha is well-positioned to expand its reach, supplying these essential medicines to international donors and procurement agencies, ultimately strengthening healthcare delivery across Nigeria and the broader West African region.

This achievement also represents a significant boost to Nigeria’s healthcare system by enhancing local manufacturing capacity and contributing to public health efforts to combat preventable diseases.

During her visit to Swipha’s facility in Lagos, USAID Mission Director to Nigeria, Ms Melissa Jones, commented “This achievement is a testament to the power of collaboration in improving healthcare in Nigeria.

“We are proud to have supported Swipha in reaching this milestone and look forward to continuing our partnership to ensure more quality medicines reach those who need them most. Together, we are building a healthier future for Nigeria.”

Continue Reading

Trending